Literature DB >> 21222055

What's wrong with too low? Is hypoglycemia a marker or a cause of CVD and mortality risk?

Anthony L McCall1.   

Abstract

Entities:  

Year:  2011        PMID： 21222055     DOI： 10.1007/s11892-010-0174-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  12 in total

1.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

2.  Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials.

Authors:  Ivan Tkác
Journal:  Diabetes Res Clin Pract       Date:  2009-12       Impact factor: 5.602

3.  Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring.

Authors:  Cyrus Desouza; Holger Salazar; Benjamin Cheong; Joseph Murgo; Vivian Fonseca
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

4.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

5.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

6.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

7.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

8.  Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Authors:  F M Turnbull; C Abraira; R J Anderson; R P Byington; J P Chalmers; W C Duckworth; G W Evans; H C Gerstein; R R Holman; T E Moritz; B C Neal; T Ninomiya; A A Patel; S K Paul; F Travert; M Woodward
Journal:  Diabetologia       Date:  2009-08-05       Impact factor: 10.122

9.  Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).

Authors:  Hertzel Gerstein; Salim Yusuf; Matthew C Riddle; Lars Ryden; Jackie Bosch
Journal:  Am Heart J       Date:  2007-11-26       Impact factor: 4.749

10.  The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.

Authors:  Denise E Bonds; Michael E Miller; Richard M Bergenstal; John B Buse; Robert P Byington; Jeff A Cutler; R James Dudl; Faramarz Ismail-Beigi; Angela R Kimel; Byron Hoogwerf; Karen R Horowitz; Peter J Savage; Elizabeth R Seaquist; Debra L Simmons; William I Sivitz; Joann M Speril-Hillen; Mary Ellen Sweeney
Journal:  BMJ       Date:  2010-01-08
View more
  1 in total

1.  Choosing targets for glycaemia, blood pressure and low-density lipoprotein cholesterol in elderly individuals with diabetes mellitus.

Authors:  Susan R Kirsh; David C Aron
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.